Progesterone 1 is a metabolic precursor common to cortisol and corticosterone biosynthesis in the adrenal cortex. However, incubation of radioactive progesterone with bovine adrenal homogenates (1) and human adrenal slices (2, 3) yields corticosterone with a specific activity greater than that of cortisol, even though the amount of cortisol produced is greater. Although hypotheses involving enzyme kinetics have been suggested to explain these results, other pathways of cortisol biosynthesis may exist that do not involve progesterone.
Compounds referred to are: progesterone (4-pregnene-3,20-dione); cortisol (11,8,17a ,21-trihydroxy-4-pregnene-3,20-dione) ; corticosterone (11, 8, 21 -dihydroxy-4-pregnene-3,20-dione); 11-deoxycortisol (17a,21-dihydroxy-4-pregnene-3,20-dione); 17-hydroxy-pregnenolone (3j8,17a-dihydroxy-5-pregnene-20-one) ; 17a-hydroxyprogesterone (17a-hydroxy-4-pregnene-3,20-dione); ACTH, adrenocorticotropic hormone.
to cortisol by slices of a hyperplastic human adrenal gland (3, 7) .
The present report describes the conyersion of 17-hydroxy-&5-pregnenolone to cortisol by slices of normal and hyperplastic human adrenal tissue. A pathway from 17-hydroxy-A5-pregnenolone-> 17-hydroxyprogesterone --11-deoxycortisol -> cortisol has been identified.
MATERIALS AND METHODS
All the adrenal glands were obtained by surgery and immediately iced until used. Adrenals were weighed, sectioned, freed of fat, reweighed, and sliced with a StadieRiggs microtome. Slices from different areas of each adrenal were taken for each experimental flask. Medullary tissue was not removed. Incubation of weighed slices was performed in a Dubnoff metabolic incubator for 3 hours at 37°C in 1 ml of Krebs-Ringer bicarbonate buffer per 30 mg of tissue with 200 mg of glucose per 100 ml in an atmosphere of 95 per cent oxygen-5 per cent CO2. The incubations were begun within 3 hours after excision of the adrenals.
The four normal adrenals were obtained from two patients with inoperable carcinoma of the prostate. Patient J.C. had had a bilateral orchiectomy and had received estrogenic therapy for 1 year prior to adrenalectomy. He received no glucocorticoid prior to the removal of the first adrenal. An infusion of 200 mg cortisol-hemisuccinate was started and the second adrenal was removed. Patient M.K. underwent a bilateral orchiectomy and received estrogenic therapy for 2 years prior to adrenalectomy. Prednisone, 20 mg each day, was administered for 3 months prior to adrenalectomy. During surgery, he received infusions of cortisol-hemisuccinate. The adrenals were of normal size.
Patient A.D., a 30-year-old female, had classical Cushing's syndrome. She received glucocorticoids on the day before and on the day of surgery. Two hyperplastic adrenals were found at surgery.
The substrate, 17a-hydroxy-A5-pregnenolone-7-H' (specific activity 2.6 mc per mg), was obtained from the New England Nuclear Corporation. It was subjected to three separate solvent partitionings (8) and then stored frozen in redistilled benezene: methanol (9: 1, vol/vol) until used. An aliquot was mixed with stable 17a-hydroxy-A'-preg-nenolone and subj ected to several different chromatography systems. A broad radioactive peak which corresponded to the broad peak of stable 17a-hydroxy-pregnenolone was found. A second minor peak of radioactivity estimated to contain less than 5 per cent of radioactive 17ca-hydroxy-pregnenolone was noted in one system. The substrate progesterone-4-C" was obtained from the New England Nuclear Corporation and subjected to two paper chromatographic systems prior to use. In experiments 1, 2, 3, and 4, 17a-hydroxy-A5-pregnenolone-H3 was added to the incubation flask either alone (experiments 1 (9) , then in the E2B system (10) . The effluents from the toluene: propylene glycol system were collected and chromatographed for 20 hours in the cyclohexane: dioxane: methanol: H2O system (100: 100: 50: 25) (11) which separated corticosterone from 1 1-deoxycortisol. The effluents from the latter system were collected and after addition of carrier 17-hydroxyprogesterone to all except experiment 1, chromatographed in the same system for 7 hours followed by the cyclohexane: benzene: methanol: water system (100:50:100:25) (11) for 8 hours.
Cortisol, 11-deoxycortisol, and corticosterone were acetylated with acetic anhydride: pyridine (1: 1) and the monoacetate derivatives chromatographed in at least two systems. Hydrolysis of cortisol acetate was carried out with acetyl cholinesterase in glycylglycine buffer and the free alcohol extracted with methylene chloride. In experiments 1 through 4, cortisol was oxidized with 2 per cent aqueous chromic acid for 18 hours at room temperature to adrenosterone which was isolated by paper chromatography in the cyclohexane: benzene: methanol: water system. Prior to chromic acid oxidation, authentic C14-cortisol was added. H3/C4 ratios were measured as the free cortisol and its adrenosterone derivative. In experiment 5, cortisol underwent bismuth oxidation to 1lp-hydroxyandrostenedione (12) which was isolated by paper chromatography in heptane: benzene: methanol: H2O (13) followed by a heptane: 96 per cent methanol system (13) .
17a-Hydroxy-progesterone was oxidized with 2 per cent aqueous chromic acid for 20 hours at room temperature to A4-androstenedione. This derivative was isolated by chromatography in the heptane: 96 per cent methanol and the cyclohexane: benzene: methanol: water systems. Specific activities were measured by alkaline fluorescence (3) or ultraviolet absorption at 240 to 242 my and by liquid scintillation counting.
RESULTS
The conversion of 17a-hydroxy-_5-pregnenolone to cortisol by human adrenal slices is illustrated in Table I . The specific activity of cortisol was not measured until after it was subjected to three successive chromatography systems as the free alcohol (toluene: propylene glycol -> Bush C -* EB). Previous experience with cortisol-H3 derived from progesterone-16-H3 indicated that this was sufficient to insure radiochemical purity (3). Table II illustrates that this holds true for cortisol derived from 17a-hydroxy-zA5-pregnenolone-7-H3. The per cent conversion represented is a minimum, since no corrections were made for losses in the purification of cortisol. In our laboratory the losses involved in extractions and purifica- t Specific activities were measured after addition of carrier 17a-hydroxyprogesterone.
Conversion to 11-deoxycortisol. In Table III , the results of conversion of 17a-hydroxy-A5-pregnenolone-7-H3 to 11-deoxycortisol are shown. Since only a few micrograms of 11-deoxycortisol were produced by the adrenals, the specific activities were measured after the addition of approximately 150 ,ug of carrier 11-deoxycortisol in experiments 2, 3, and 4. In experiment 1 the addition of 1 7a-hydroxy-progesterone increased the production of 1 1-deoxycortisol ment 1, where carrier 17a-hydroxyprogesterone was added to the media prior to incubation, no 17a-hydroxyprogesterone was detected on the chromatograms by ultraviolet scanning. Specific activities were measured after the addition of carrier 17a-hydroxyprogesterone. In 3 of 4 experiments radiochemical purity was demonstrated as the free alcohol, and after oxidation A4-androstenedione. The highest per cent incorporation of 17a-hydroxy-&5-pregnenolone to 17a-hydroxyprogesterone occurred in the "trapping" experiment 1.
Comparison of conversion of progesterone-4-C14 and 17a-hydroxy-pregnenolone-7-H3 to cortisol by slices of a hyperplastic gland. The results of the simultaneous incubation of equimolar concentrations of progesterone-4-C14 and 1 7a-hydroxy-Y5-pregnenolone-7-H3 with slices of a hyperplastic human adrenal gland obtained from patient with Cushing's syndrome are shown in Table V . The addition of ACTH in vitro did not significantly alter the production of cortisol or the conversion of the precursor. Slightly more progesterone was converted to cortisol than 17a-hydroxy-A5-pregnenolone. slices of human, guinea pig, and rat adrenals metabolized 17a-hydroxy-A5-pregnenolone-H3 to cortisol via a pathway identical to one described in the present study. They found that 9 per cent of the labeled 17a-hydroxy-'5-pregnenolone was converted to cortisol. The extent of conversion of 17a-hydroxy-A5-pregnenolone to cortisol in vitro compares favorably with the conversion of progesterone to cortisol. In a previous study (3), the present authors found that slices of a normal adrenal gland converted 6.8 per cent of tracer quantities of progesterone-16-H3, whereas slices of hyperplastic or adenomatous adrenal tissue converted 5.8 to 16.2 per cent. In experiment 5 of the present study, incubation of an equimolar concentration of 17a-hydroxy-A&5-pregnenolone-7-H3 and progesterone-4-C14 with slices of a hyperplastic adrenal resulted in a greater per cent conversion of progesterone-4-C14 than 17a-hydroxy-_5-pregnenolone-H3. Weliky and Engel (6) in a similar type of experiment found that a human adrenal adenoma converted 50 per cent of 17a-hydroxy-A'5-pregnenolone and 15 per cent of progesterone-C14 to cortisol. This type of experiment is difficult to interpret, however, since the results may be influenced by many factors, such as rates of penetration of the two substrates into their enzyme sites, size of intracellular pools of intermediates in the respective pathways, and activity of the enzymes in vitro. Moreover, in vitro experiments may not reflect the biosynthetic events occurring in vivo. Since progesterone and 17a-hydroxy-A--pregnenolone are derived from a common precursor, pregnenolone, the relative importance of the two pathways of cortisol biosynthesis depends upon: 1) the rates of conversion of pregnenolone to either progesterone or 17a-hydroxy-A5-pregnenolone, and 2) their rates of conversion to 17-hydroxyprogesterone. The enzyme systems involved in the latter reactions would have to compete with the enzyme systems which metabolize progesterone and 17a-hydroxy-A5-pregnenolone to compounds other than 17-hydroxyprogesterone.
Nevertheless, since a pathway from 17a-hydroxy-A5-pregnenolone to cortisol has been demonstrated to exist in vitro, it is a possibility that one reason for the lower specific activity of cortisol compared to corticosterone when radioactive progesterone is incubated with human adrenal tissue is the presence of an alternative pathway of cortisol synthesis. Production of cortisol by way of this alternative pathway might "dilute" the cortisol derived from radioactive progesterone.
SUMMARY
Conversion of 1 7a-hydroxy-A5-pregnenolone-7-H3 to cortisol by slices of four normal adrenals and one hyperplastic adrenal has been demonstrated. The slices of normal adrenal tissue converted from 9 to 19 per cent of the 17a-hydroxy-A5-pregnenolone-7-H3 to cortisol, whereas slices of the hyperplastic gland incorporated 5 per cent.
A pathway from 17a-hydroxv-yA5-pregnenolone 17a-hydroxy-progesterone 11 -deoxycortisol > cortisol has been identified.
